Results 1 - 20 of 59 in Dynavax Technologies
-
Semi-Annual Changes to the NASDAQ Biotechnology Index
... a result of the re-ranking, Cell Therapeutics, Inc. (Nasdaq:CTIC), deCODE genetics, Inc. (Nasdaq:DCGN), Dynavax Technologies Corp. (Nasdaq:DVAX), EPIX Pharmaceuticals, Inc. (Nasdaq:EPIX), ISTA Pharmaceuticals, Inc. (Nasdaq:ISTA), MDRNA, Inc. ...
Comment?
-
Semi-Annual Changes to the NASDAQ Biotechnology Index
... a result of the re-ranking, Cell Therapeutics, Inc. (Nasdaq:CTIC), deCODE genetics, Inc. (Nasdaq:DCGN), Dynavax Technologies Corp. (Nasdaq:DVAX), EPIX Pharmaceuticals, Inc. (Nasdaq:EPIX), ISTA Pharmaceuticals, Inc. (Nasdaq:ISTA), MDRNA, Inc. ...
Comment?
-
Public relations, press release distribution, investor relations, SEC filing
... September 30, 2008. For the quarter, the Company posted net income - BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that on November 10, 2008, the Company received a notice from The Nasdaq Stock ...
Comment?
-
Dynavax Announces Receipt of Notice of Failure to Satisfy a Continued ...
Dynavax Technologies Corporation announced today that on November 10, 2008, the Company received a notice from The Nasdaq Stock Market indicating that the Company is not in compliance with the continued listing ...
Comment?
-
The Nasdaq warned Dynavax Technologies Corp. it doesn't meet a minimum shareholders' equity rule for listing on the exchange.
Comment?
-
Dynavax to Present at Credit Suisse Healthcare Conference
www.dynavax.com - Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that it will present at the Credit Suisse 2008 Healthcare Conference on Wednesday, November 12, 2008 at 3:00 p.m. MST (2:00 p.m. PST) in Phoenix, Arizona. Dino Dina, ...
Comment?
-
Dynavax to Present at Credit Suisse Healthcare Conference
Dynavax Technologies Corporation announced today that it will present at the Credit Suisse 2008 Healthcare Conference on Wednesday, November 12, 2008 at 3:00 p.m. MST in Phoenix, Arizona.
Comment?
-
Dynavax cuts loss through collaboration
A boost in revenue from a collaborative agreement with Merck & Co. helped Dynavax Technologies Corp.
Comment?
-
... the $2.43 a share that analysts poll by FactSet had predicted. Revenues fell 6 percent. Berkeley-based Dynavax Technologies Corp. reported a smaller loss and a nearly nine-fold increase in revenue for its third quarter of 2008. The maker of vaccines ...
Comment?
-
Dynavax Announces Third Quarter 2008 Financial Results
Dynavax Technologies Corporation today reported financial results for the third quarter and nine months ended September 30, 2008.
Comment?
-
Dynavax to Report Third Quarter 2008 Financial Results : -- To...
Dynavax Technologies Corporation announced today that it plans to report third quarter 2008 financial results before the market opens on Monday, November 3, 2008.
Comment?
-
Technical Trade Alerts on Market Movers: DVAX, TLAB, CRESY, HSNI, SCMR, NAPS
... ) DALLAS, Texas - Beacon Equity Research announces the release of Trade Alerts covering Market Movers: Dynavax Technologies Corp. (Nasdaq: DVAX), Tellabs Inc. (Nasdaq: TLAB), Cresud Inc. (Nasdaq: CRESY), HSN Inc. (Nasdaq: HSNI), Sycamore Networks ...
Comment?
-
Beacon Equity Issues Technical Trade Alerts on Market Movers: DVAX, TLAB, CRESY, HSNI, SCMR, NAPS
... daily trading notes for free by visiting: http://www.BeaconEquity.com/m Today's Trade Alerts include: Dynavax Technologies Corp. (Nasdaq: DVAX), Tellabs Inc. (Nasdaq: TLAB ), Cresud Inc. (Nasdaq: CRESY ), HSN Inc. (Nasdaq: HSNI ), Sycamore Networks ...
Comment?
-
Dynavax And Merck Provide Update On U.S. FDA Clinical Hold On...
Main Category: Liver Disease / Hepatitis Also Included In: Immune System / Vaccines ; Regulatory Affairs / Drug Approvals Article Date: 22 Oct 2008 - 9:00 PDT Dynavax Technologies Corporation and Merck & Co., ...
Comment?
-
Dynavax And Merck Provide Update On U.S. FDA Clinical Hold On Investigational Vaccine HEPLISAVa
Main Category: Liver Disease / Hepatitis Also Included In: Immune System / Vaccines Dynavax Technologies Corporation and Merck & Co., Inc.
Comment?
-
Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical...
Dynavax Technologies Corporation and Merck & Co., Inc. have received communication from the U.S. Food and Drug Administration regarding the two companies' response to the agency's request for safety information ...
Comment?
-
Dynavax Technologies Corporation , Merck & Co., Inc. Say Hepatitis Vaccine Still on Hold
Dynavax Technologies Corporation , Merck & Co., Inc. Say Hepatitis Vaccine Still on Hold 10/22/2008 BERKELEY, Calif.
Comment?
-
Dynavax Awarded $17 Million Contract from National Institutes of Health
Dynavax Technologies Corporation has been awarded a $17 million contract to develop its advanced immunostimulatory sequences technology using Toll-Like Receptor 9 agonists as vaccine adjuvants.
Comment?
-
National Institutes of Health gives Dynavax a $17M contract
Berkeley's Dynavax Technologies Corp. will develop immune system triggers useful for vaccines under a $17 million contract from the National Institutes of Health.
Comment?
-
Dynavax Awarded $17 Million Contract from National Institutes of...
... response and can contribute to increased product stability. About Dynavax Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of infectious ...
Comment?
Dynavax Technologies Forum
Most Popular